These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1688062)

  • 21. Celiprolol--new clinical perspectives beyond cardioselectivity. Proceedings of a symposium. Madrid, Spain, 24 January 1987.
    J Int Med Res; 1988; 16 Suppl 1():1A-80A. PubMed ID: 2906014
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical performance and therapeutic potential of celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S9-13. PubMed ID: 2481791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double blind placebo controlled study of celiprolol in the treatment of angina pectoris.
    Harston WE; Eff J; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():55-8. PubMed ID: 2864066
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of celiprolol and propranolol in the treatment of hypertension in one hundred and seventy-nine subjects.
    Leary P; Mayol R; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():70-2. PubMed ID: 2864068
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study.
    Stumpe K; Kolloch R; Mathieu M; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():73-5. PubMed ID: 2864069
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative study of celiprolol and chlorthalidone in hypertensive patients with reversible airways obstruction.
    Capone P; Mayol R; Mathieu M
    Br J Clin Pract Suppl; 1985 Jun; 40():37-9. PubMed ID: 2864061
    [No Abstract]   [Full Text] [Related]  

  • 27. Celiprolol--new therapeutic horizons in beta blockade. Proceedings of a workshop. Tarrytown, New York, 16 January 1985.
    Br J Clin Pract Suppl; 1985 Jun; 40():1-100. PubMed ID: 2864055
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of celiprolol on the bronchial reactivity in asthma.
    Bruschi C; Casali L; Cerveri I; Peona V; Zoia MC
    Am J Cardiol; 1988 Feb; 61(5):53C-54C. PubMed ID: 2893534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Celiprolol, clinical dosage, efficacy and safety in asthmatic and elderly patients.
    Hitzenberger G
    Br J Clin Pract Suppl; 1985 Jun; 40():25-32. PubMed ID: 2864058
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of the cardioselective beta blocker celiprolol on pulmonary function in asthmatic patients.
    Schindl R; Würtz J; Hoffmann H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S99-101. PubMed ID: 2427862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Celiprolol in the treatment of chronic stable angina].
    Román O; Cuevas G; Martínez D; Vargas W
    Rev Med Chil; 1991 Jan; 119(1):50-5. PubMed ID: 1688095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
    Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisoprolol--another cardioselective beta blocker.
    Drug Ther Bull; 1989 Jul; 27(14):55-6. PubMed ID: 2577508
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical studies of celiprolol in the treatment of arterial hypertension].
    Belovezhdov N; Nachev Ch; Angelova I; Gergova V; Stefanov G
    Vutr Boles; 1985; 24(5):74-7. PubMed ID: 2868573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings of a symposium. Beta-blockers: perspectives beyond cardioselectivity. An official satellite to the second Cardiovascular Pharmacotherapy International Symposium. San Francisco, California, October 21, 1987.
    Am Heart J; 1988 Nov; 116(5 Pt 2):1383-440. PubMed ID: 2903647
    [No Abstract]   [Full Text] [Related]  

  • 38. Celiprolol and risk factor reversal in hypertension.
    Taylor SH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S33-9. PubMed ID: 2481788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP; Lamon KD; Hagen NS
    J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The cardioselective beta blocker bisoprolol. Value in the therapy of florid hyperthyroidism].
    Jungmann E; Rosak C; Schifferdecker E; Schumm-Draeger PM; Schöffling K
    Fortschr Med; 1986 Sep; 104(35):661-4. PubMed ID: 2876939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.